Study in Asymptomatic GRN-FTD Patients to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001

Clinical trial NCT06705192 · COMPLETED

Trial details

NCT number: NCT06705192
Sponsor: Mads Kjolby
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dementia Frontotemporal Dementia Asymptomatic Condition

Start date: 2024-12-12
Primary completion: 2025-08-05
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.